{"id":7100,"date":"2025-01-24T15:22:00","date_gmt":"2025-01-24T08:22:00","guid":{"rendered":"https:\/\/www.globenewswire.com\/news-release\/2025\/01\/24\/3014725\/0\/en\/Form-8-5-EPT-RI-Alliance-Pharma-plc.html3014725"},"modified":"2025-01-24T15:24:31","modified_gmt":"2025-01-24T08:24:31","slug":"form-8-5-ept-ri-alliance-pharma-plc","status":"publish","type":"post","link":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/","title":{"rendered":"Form 8.5 (EPT\/RI) - Alliance Pharma plc"},"content":{"rendered":"\n

FORM 8.5 (EPT\/RI) <\/strong><\/p>\n

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY<\/strong>
Rule 8.5 of the Takeover Code (the \u201cCode\u201d)<\/strong><\/p>\n

1.        KEY INFORMATION<\/strong><\/p>\n

\n\n\n\n\n\n
(a)        Name of exempt principal trader:<\/strong><\/td>\nInvestec Bank plc<\/td>\n<\/tr>\n
(b)        Name of offeror\/offeree in relation to whose relevant securities this form relates:<\/strong>
        Use a separate form for each offeror\/offeree<\/em><\/td>\n		Alliance Pharma plc<\/td>\n<\/tr>\n
(c)        Name of the party to the offer with which exempt principal trader is connected:<\/strong><\/td>\nInvestec is financial advisor to Aegros Bidco Limited (a newly incorporated company indirectly owned by DBAY Affiliates and the ERES IV Fund) <\/td>\n<\/tr>\n
(d)        Date dealing undertaken:<\/strong><\/td>\n23rd<\/sup> January 2025<\/td>\n<\/tr>\n
(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?<\/strong>
        <\/strong>If it is a cash offer or possible cash offer, state \u201cN\/A\u201d<\/em><\/td>\n		N\/A<\/em><\/td>\n<\/tr>\n<\/table><\/div>\n

2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER<\/strong><\/p>\n

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.<\/em><\/p>\n

The currency of all prices and other monetary amounts should be stated.<\/em><\/p>\n

(a)        Purchases and sales<\/strong><\/p>\n

\n\n\n
Class of relevant security<\/strong><\/td>\nPurchases\/ sales<\/strong> <\/td>\nTotal number of securities<\/strong><\/td>\nHighest price per unit paid\/received<\/strong><\/td>\nLowest price per unit paid\/received<\/strong><\/td>\n<\/tr>\n
\n

Ordinary shares<\/p>\n<\/td>\n

\n

Sales<\/p>\n<\/td>\n

\n

458,503<\/p>\n<\/td>\n

\n

61.2<\/p>\n<\/td>\n

\n

61.2<\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

(b)        Cash-settled derivative transactions<\/strong><\/p>\n

\n\n\n
Class of relevant security<\/strong><\/td>\nProduct description<\/strong>
e.g. CFD<\/em><\/td>\n		Nature of dealing<\/strong>
e.g. opening\/closing a long\/short position, increasing\/reducing a long\/short position<\/em><\/td>\n		Number of reference securities<\/strong><\/td>\nPrice per unit<\/strong><\/td>\n<\/tr>\n
N\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\n<\/tr>\n<\/table><\/div>\n

(c)        Stock-settled derivative transactions (including options)<\/strong><\/p>\n

(i)        Writing, selling, purchasing or varying<\/strong><\/p>\n

\n\n\n
Class of relevant security<\/strong><\/td>\nProduct description <\/strong>e.g. call option<\/em><\/td>\nWriting, purchasing, selling, varying etc.<\/strong><\/td>\nNumber of securities to which option relates<\/strong><\/td>\nExercise price per unit<\/strong><\/td>\nType<\/strong>
e.g. American, European etc.<\/em><\/td>\n		Expiry date<\/strong><\/td>\nOption money paid\/ received per unit<\/strong><\/td>\n<\/tr>\n
N\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\n<\/tr>\n<\/table><\/div>\n

(ii)        Exercise<\/strong><\/p>\n

\n\n\n
Class of relevant security<\/strong><\/td>\nProduct description<\/strong>
e.g. call option<\/em><\/td>\n		Exercising\/ exercised against<\/strong><\/td>\nNumber of securities<\/strong><\/td>\nExercise price per unit<\/strong><\/td>\n<\/tr>\n
N\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\n<\/tr>\n<\/table><\/div>\n

(d)        Other dealings (including subscribing for new securities)<\/strong><\/p>\n

\n\n\n
Class of relevant security<\/strong><\/td>\nNature of dealing<\/strong>
e.g. subscription, conversion<\/em><\/td>\n		Details<\/strong><\/td>\nPrice per unit (if applicable)<\/strong><\/td>\n<\/tr>\n
N\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\nN\/A<\/td>\n<\/tr>\n<\/table><\/div>\n

3.        OTHER INFORMATION<\/strong><\/p>\n

(a)        Indemnity and other dealing arrangements<\/strong><\/p>\n

\n\n\n
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:<\/strong>
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state \u201cnone\u201d<\/em><\/td>\n<\/tr>\n
\n

None <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

(b)        Agreements, arrangements or understandings relating to options or derivatives<\/strong><\/p>\n

\n\n\n
Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:<\/strong>
(i)        the voting rights of any relevant securities under any option; or <\/strong>
(ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:<\/strong>
If there are no such agreements, arrangements or understandings, state \u201cnone\u201d<\/em><\/td>\n<\/tr>\n
None <\/td>\n<\/tr>\n<\/table><\/div>\n
\n\n\n\n
Date of disclosure:<\/strong><\/td>\n24<\/strong>th<\/strong><\/sup> January 2025<\/strong><\/td>\n<\/tr>\n
Contact name:<\/strong><\/td>\nAbhishek Gawde<\/strong><\/td>\n<\/tr>\n
Telephone number:<\/strong><\/td>\n+91 9923757332<\/strong><\/td>\n<\/tr>\n<\/table><\/div>\n

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. <\/em><\/p>\n

The Panel\u2019s Market Surveillance Unit is available for consultation in relation to the Code\u2019s dealing disclosure requirements on +44 (0)20 7638 0129.<\/em><\/p>\n

The Code can be viewed on the Panel\u2019s website at <\/em>www.thetakeoverpanel.org.uk<\/u><\/em><\/a>.<\/em><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

FORM 8.5 (EPT\/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the \u201cCode\u201d) 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of exempt principal trader:Investec Bank plc(b)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of offeror\/offeree in relation to whose relevant securities this form relates: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Use a separate form for each offeror\/offereeAlliance Pharma plc(c)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly…<\/p>\n","protected":false},"author":1,"featured_media":7101,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[75,1406],"tags":[],"class_list":["post-7100","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-globenewswire"],"yoast_head":"\nForm 8.5 (EPT\/RI) - Alliance Pharma plc<\/title>\n<meta name=\"description\" content=\"FORM 8.5 (EPT\/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the \u201cCode\u201d) 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of exempt principal trader:Investec Bank plc(b)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of offeror\/offeree in relation to whose relevant securities this form relates: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Use a separate form for each offeror\/offereeAlliance Pharma plc(c)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Form 8.5 (EPT\/RI) - Alliance Pharma plc\" \/>\n<meta property=\"og:description\" content=\"FORM 8.5 (EPT\/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the \u201cCode\u201d) 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of exempt principal trader:Investec Bank plc(b)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of offeror\/offeree in relation to whose relevant securities this form relates: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Use a separate form for each offeror\/offereeAlliance Pharma plc(c)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/\" \/>\n<meta property=\"og:site_name\" content=\"Crypto Insider\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/yourcryptoinsider\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-24T08:22:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-24T08:24:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/YWUwOWRiZjEtMjM5Ni00MjJhLWI2ZTMtZGNmMTI1ZTcxYWRhLTEwMTQ2MDk=\/tiny\/INVESTEC-BANK-PLC.png\" \/>\n<meta name=\"author\" content=\"Crypto Insider\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"Crypto Insider\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/\"},\"author\":{\"name\":\"Crypto Insider\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\"},\"headline\":\"Form 8.5 (EPT\\\/RI) - Alliance Pharma plc\",\"datePublished\":\"2025-01-24T08:22:00+00:00\",\"dateModified\":\"2025-01-24T08:24:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/\"},\"wordCount\":805,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/form-8-5-ept-ri-alliance-pharma-plc.gif\",\"articleSection\":[\"Business\",\"GlobeNewswire\"],\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/\",\"name\":\"Form 8.5 (EPT\\\/RI) - Alliance Pharma plc - Crypto Insider\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/form-8-5-ept-ri-alliance-pharma-plc.gif\",\"datePublished\":\"2025-01-24T08:22:00+00:00\",\"dateModified\":\"2025-01-24T08:24:31+00:00\",\"description\":\"Crypto and Blockchain News\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/#breadcrumb\"},\"inLanguage\":\"vi\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/form-8-5-ept-ri-alliance-pharma-plc.gif\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/form-8-5-ept-ri-alliance-pharma-plc.gif\",\"width\":1,\"height\":1},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/form-8-5-ept-ri-alliance-pharma-plc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Business\",\"item\":\"https:\\\/\\\/cryptoinsider.asia\\\/category\\\/business\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Form 8.5 (EPT\\\/RI) - Alliance Pharma plc\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"name\":\"Crypto Insider\",\"description\":\"Crypto and Blockchain News\",\"publisher\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vi\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#organization\",\"name\":\"Crypto Insider\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"contentUrl\":\"https:\\\/\\\/cryptoinsider.asia\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Logo-crypto-insider.jpeg\",\"width\":2048,\"height\":2048,\"caption\":\"Crypto Insider\"},\"image\":{\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/yourcryptoinsider\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/vietnaminsider\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cryptoinsider.asia\\\/#\\\/schema\\\/person\\\/e81ca31713268a414ddbed321d3383d6\",\"name\":\"Crypto Insider\",\"description\":\"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain\",\"sameAs\":[\"https:\\\/\\\/cryptoinsider.asia\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Form 8.5 (EPT\/RI) - Alliance Pharma plc","description":"FORM 8.5 (EPT\/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the \u201cCode\u201d) 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of exempt principal trader:Investec Bank plc(b)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of offeror\/offeree in relation to whose relevant securities this form relates: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Use a separate form for each offeror\/offereeAlliance Pharma plc(c)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"FORM 8.5 (EPT\/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the \u201cCode\u201d) 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of exempt principal trader:Investec Bank plc(b)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of offeror\/offeree in relation to whose relevant securities this form relates: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Use a separate form for each offeror\/offereeAlliance Pharma plc(c)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly...","og_locale":"vi_VN","og_type":"article","og_title":"Form 8.5 (EPT\/RI) - Alliance Pharma plc","og_description":"FORM 8.5 (EPT\/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the \u201cCode\u201d) 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0KEY INFORMATION (a)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of exempt principal trader:Investec Bank plc(b)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of offeror\/offeree in relation to whose relevant securities this form relates: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Use a separate form for each offeror\/offereeAlliance Pharma plc(c)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Name of the party to the offer with which exempt principal trader is connected:Investec is financial advisor to Aegros Bidco Limited (a newly...","og_url":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/","og_site_name":"Crypto Insider","article_publisher":"https:\/\/www.facebook.com\/yourcryptoinsider","article_published_time":"2025-01-24T08:22:00+00:00","article_modified_time":"2025-01-24T08:24:31+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/YWUwOWRiZjEtMjM5Ni00MjJhLWI2ZTMtZGNmMTI1ZTcxYWRhLTEwMTQ2MDk=\/tiny\/INVESTEC-BANK-PLC.png","type":"","width":"","height":""}],"author":"Crypto Insider","twitter_card":"summary_large_image","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"Crypto Insider","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"4 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/#article","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/"},"author":{"name":"Crypto Insider","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6"},"headline":"Form 8.5 (EPT\/RI) - Alliance Pharma plc","datePublished":"2025-01-24T08:22:00+00:00","dateModified":"2025-01-24T08:24:31+00:00","mainEntityOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/"},"wordCount":805,"commentCount":0,"publisher":{"@id":"https:\/\/cryptoinsider.asia\/#organization"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/01\/form-8-5-ept-ri-alliance-pharma-plc.gif","articleSection":["Business","GlobeNewswire"],"inLanguage":"vi","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/","url":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/","name":"Form 8.5 (EPT\/RI) - Alliance Pharma plc - Crypto Insider","isPartOf":{"@id":"https:\/\/cryptoinsider.asia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/#primaryimage"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/#primaryimage"},"thumbnailUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/01\/form-8-5-ept-ri-alliance-pharma-plc.gif","datePublished":"2025-01-24T08:22:00+00:00","dateModified":"2025-01-24T08:24:31+00:00","description":"Crypto and Blockchain News","breadcrumb":{"@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/#breadcrumb"},"inLanguage":"vi","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/"]}]},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/#primaryimage","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/01\/form-8-5-ept-ri-alliance-pharma-plc.gif","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/01\/form-8-5-ept-ri-alliance-pharma-plc.gif","width":1,"height":1},{"@type":"BreadcrumbList","@id":"https:\/\/cryptoinsider.asia\/vi\/form-8-5-ept-ri-alliance-pharma-plc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cryptoinsider.asia\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/cryptoinsider.asia\/category\/news\/"},{"@type":"ListItem","position":3,"name":"Business","item":"https:\/\/cryptoinsider.asia\/category\/business\/"},{"@type":"ListItem","position":4,"name":"Form 8.5 (EPT\/RI) - Alliance Pharma plc"}]},{"@type":"WebSite","@id":"https:\/\/cryptoinsider.asia\/vi\/#website","url":"https:\/\/cryptoinsider.asia\/vi\/","name":"Crypto Insider","description":"Crypto and Blockchain News","publisher":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cryptoinsider.asia\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vi"},{"@type":"Organization","@id":"https:\/\/cryptoinsider.asia\/vi\/#organization","name":"Crypto Insider","url":"https:\/\/cryptoinsider.asia\/vi\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","contentUrl":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2021\/11\/Logo-crypto-insider.jpeg","width":2048,"height":2048,"caption":"Crypto Insider"},"image":{"@id":"https:\/\/cryptoinsider.asia\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/yourcryptoinsider","https:\/\/www.linkedin.com\/company\/vietnaminsider"]},{"@type":"Person","@id":"https:\/\/cryptoinsider.asia\/#\/schema\/person\/e81ca31713268a414ddbed321d3383d6","name":"Crypto Insider","description":"Tin t\u1ee9c v\u1ec1 Ti\u1ec1n \u0111i\u1ec7n t\u1eed v\u00e0 c\u00f4ng ngh\u1ec7 Blockchain","sameAs":["https:\/\/cryptoinsider.asia"]}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/cryptoinsider.asia\/wp-content\/uploads\/2025\/01\/form-8-5-ept-ri-alliance-pharma-plc.gif","jetpack-related-posts":[],"jetpack_likes_enabled":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/7100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/comments?post=7100"}],"version-history":[{"count":0,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/posts\/7100\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media\/7101"}],"wp:attachment":[{"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/media?parent=7100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/categories?post=7100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cryptoinsider.asia\/vi\/wp-json\/wp\/v2\/tags?post=7100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}